OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
Salvatore Petta, Angelo Armandi, Elisabetta Bugianesi
Liver International (2024)
Open Access | Times Cited: 9
Salvatore Petta, Angelo Armandi, Elisabetta Bugianesi
Liver International (2024)
Open Access | Times Cited: 9
Showing 9 citing articles:
The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 5
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 5
Evolutionäre Aspekte der mit metabolischer Dysfunktion assoziierten steatotischen Lebererkrankung (MASLD)
Andreas Geier, Stephan Schiffels, Marcin Krawczyk
Deleted Journal (2025)
Closed Access
Andreas Geier, Stephan Schiffels, Marcin Krawczyk
Deleted Journal (2025)
Closed Access
Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans
Hannele Yki‐Järvinen, Panu K. Luukkonen
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Hannele Yki‐Järvinen, Panu K. Luukkonen
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease
Sheetalnath Rooge, Nirajan Shrestha
Frontiers in Medicine (2025) Vol. 12
Open Access
Sheetalnath Rooge, Nirajan Shrestha
Frontiers in Medicine (2025) Vol. 12
Open Access
The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
Harendran Elangovan, Jenny E. Gunton, Ming‐Hua Zheng, et al.
Hepatology International (2025)
Open Access
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database
Pojsakorn Danpanichkul, Yanfang Pang, Thanida Auttapracha, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1133-1133
Open Access
Pojsakorn Danpanichkul, Yanfang Pang, Thanida Auttapracha, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1133-1133
Open Access
Gustavo Ayares, Luis Antonio Díaz, Francisco Idalsoaga, et al.
Liver International (2025) Vol. 45, Iss. 5
Open Access
Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD)
Lucy C. Taylor, Gertrude Arthur, Miguel Cruz, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 4, pp. 782-809
Open Access | Times Cited: 1
Lucy C. Taylor, Gertrude Arthur, Miguel Cruz, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 4, pp. 782-809
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos‐Molina
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access
